iRhythm Technologies (NSDQ:IRTC) this week said it would not be filing its quarterly report on Form 10-Q, citing previously disclosed material weaknesses, according to an SEC filing.
The San Francisco-based company said it identified errors that affected prior periods while preparing the quarterly report for the period ended Sept. 30, 2019. The errors could affect the previously issued annual and quarterly financial statements, the SEC filing said.
While evaluating the error, iRhythm Technologies plans to include the assessment of any additional control deficiencies and plans to file its quarterly report as soon as it can.
iRhythm Technologies in September closed an underwritten public offering of common stock that totaled nearly $115 million, following a $13 million deal with Verily to develop AI-based screening, diagnosis and management technology for atrial fibrillation.